| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 47,966 | 41,173 | 29,322 | 34,709 | | Cost of Revenue | 18,868 | 16,823 | 12,431 | 14,564 | | | Gross Profit | 29,098 | 24,350 | 16,891 | 20,145 | | | Operating Expenses | | Research Development | 10,080 | 9,732 | 8,117 | 9,256 | | Selling General and Administrative | 9,438 | 9,321 | 7,808 | 8,056 | | Non Recurring | (3,545) | 2,233 | 2,046 | 594 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 13,125 | 3,064 | (1,080) | 2,239 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 161 | 281 | 385 | 7 | | Earnings Before Interest And Taxes | 13,286 | 3,345 | (695) | 2,246 | | Interest Expense | 76 | 185 | 94 | (507) | | Income Before Tax | 13,210 | 3,160 | (789) | 2,753 | | Income Tax Expense | 648 | (26) | (61) | (481) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,562 | 3,186 | (728) | 3,234 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,562 | 3,186 | (728) | 3,234 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,562 | $3,186 | ($728) | $3,234 |
|
0.02% Nasdaq 
0.33%
Income Statement
